Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study.

NCT04095208 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT04095208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04095208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study.
Lead sponsor
Institut Bergonié
Phase
Phase 2
Overall status
Completed
Start date
February 27, 2020
Completion date
March 29, 2026
Enrollment
68 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, soft tissue sarcoma adult